Evaluation of Gadoterate in Patients With Decreased Kidney Function
Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study is for individuals with decreased kidney function whose doctor has ordered
Magnetic Resonance Imaging (MRI). Because kidney function is decreased, these patients
usually do not receive the intravenous contrast material that can improve the accuracy of the
MRI findings. The purpose of this study is to evaluate the safety and benefit of using a
contrast material called Gadoterate in patients with decreased kidney function.